Get started
Work

Supplemental Figure S3 from Enhancing Standard of Care Chemotherapy Efficacy Using DNA-Dependent Protein Kinase (DNA-PK) Inhibition in Preclinical Models of Ewing Sarcoma

Year: 2024
Type: supplementary-materials
Abstract: The synergistic combination of the DNA-PK inhibitor M3814 and etoposide extends to multiple Ewing sarcoma cell lines
DOI: 10.1158/1535-7163.26423728.v1
Authors: Victor J. Collins, Katelyn R. Ludwig, Ariana E. Nelson, Soumya Sundara Rajan, Choh Yeung, Ksenia Vulikh, Kristine A. Isanogle, Arnulfo Mendoza, Simone Difilippantonio, Baktiar O. Karim, Natasha J. Caplen, Christine M. Heske
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4401204248
Cites:
Cited by:
Related to: 10